Loading…

Is a first acute symptomatic seizure epilepsy? Mortality and risk for recurrent seizure

Summary Purpose:  To compare mortality and subsequent unprovoked seizure risk in a population‐based study of acute symptomatic seizure and first unprovoked seizure due to static brain lesions. Methods:  We ascertained all first episodes of acute symptomatic seizure and unprovoked seizure due to cent...

Full description

Saved in:
Bibliographic Details
Published in:Epilepsia (Copenhagen) 2009-05, Vol.50 (5), p.1102-1108
Main Authors: Hesdorffer, Dale C., Benn, Emma K. T., Cascino, Gregory D., Hauser, W. Allen
Format: Article
Language:English
Subjects:
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
cited_by cdi_FETCH-LOGICAL-c4635-36b862f5e94b53f817380fba7027c2bf61d516e3a6a2a589d6aea3249f433743
cites cdi_FETCH-LOGICAL-c4635-36b862f5e94b53f817380fba7027c2bf61d516e3a6a2a589d6aea3249f433743
container_end_page 1108
container_issue 5
container_start_page 1102
container_title Epilepsia (Copenhagen)
container_volume 50
creator Hesdorffer, Dale C.
Benn, Emma K. T.
Cascino, Gregory D.
Hauser, W. Allen
description Summary Purpose:  To compare mortality and subsequent unprovoked seizure risk in a population‐based study of acute symptomatic seizure and first unprovoked seizure due to static brain lesions. Methods:  We ascertained all first episodes of acute symptomatic seizure and unprovoked seizure due to central nervous system (CNS) infection, stroke, and traumatic brain injury (TBI). Subjects were residents of Rochester, Minnesota, identified through the Rochester Epidemiology Project’s records‐linkage system between 1/1/55 and 12/31/84. Information was collected on age, gender, seizure type, etiology, status epilepticus (SE), 30‐day and 10‐year mortality, and subsequent episodes of unprovoked seizure. Results:  Two hundred sixty‐two individuals experienced a first acute symptomatic seizure and 148 individuals experienced a first unprovoked seizure, all due to static brain lesions. Individuals with a first acute symptomatic seizure were 8.9 times more likely to die within 30 days compared to those with a first unprovoked seizure [95% confidence intervals (CI) = 3.5–22.5] after adjustment for age, gender, and SE. Among 30‐day survivors, the risk of 10‐year mortality did not differ. Over the 10‐year period, individuals with a first acute symptomatic seizure were 80% less likely to experience a subsequent unprovoked seizure compared with individuals with a first unprovoked seizure [adjusted rate ratio (RR) = 0.2, 95% CI = 0.2–0.4]. Discussion:  The prognosis of first acute symptomatic seizures differs from that of first unprovoked seizure when the etiology is stroke, TBI, and CNS infection. Acute symptomatic seizures have a higher early mortality and a lower risk for subsequent unprovoked seizure. These differences argue against the inclusion of acute symptomatic seizures as epilepsy.
doi_str_mv 10.1111/j.1528-1167.2008.01945.x
format article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_67323272</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>67323272</sourcerecordid><originalsourceid>FETCH-LOGICAL-c4635-36b862f5e94b53f817380fba7027c2bf61d516e3a6a2a589d6aea3249f433743</originalsourceid><addsrcrecordid>eNqNkE1r3DAQhkVoSLZp_kLQpb3Z1Ycl2YdSStg0CxuSQ6BHMdZKoK29diWbrvvrI2c322t0GcE870jzIIQpyWk6X7c5FazMKJUqZ4SUOaFVIfL9GVqcGh_QghDKs0qU5BJ9jHFLCFFS8Qt0SSuuCinUAv1aRQzY-RAHDGYcLI5T2w9dC4M3OFr_bwwW2943to_Td_zQhQEaP0wYdhscfPyNXRdwsGYMwe6Gt8gndO6gifb6WK_Q893y-fY-Wz_-XN3-WGemkFxkXNalZE7YqqgFdyVVvCSuBkWYMqx2km4ElZaDBAairDYSLHBWVK7gaQV-hb4cxvah-zPaOOjWR2ObBna2G6NO6zLOFEtgeQBN6GIM1uk--BbCpCnRs1O91bM6PavTs1P96lTvU_Tm-MZYt3bzP3iUmIDPRwCigcYF2BkfTxxLcwupqsR9O3B_k83p3R_Qy6fVfOMvzraScw</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>67323272</pqid></control><display><type>article</type><title>Is a first acute symptomatic seizure epilepsy? Mortality and risk for recurrent seizure</title><source>Wiley</source><creator>Hesdorffer, Dale C. ; Benn, Emma K. T. ; Cascino, Gregory D. ; Hauser, W. Allen</creator><creatorcontrib>Hesdorffer, Dale C. ; Benn, Emma K. T. ; Cascino, Gregory D. ; Hauser, W. Allen</creatorcontrib><description>Summary Purpose:  To compare mortality and subsequent unprovoked seizure risk in a population‐based study of acute symptomatic seizure and first unprovoked seizure due to static brain lesions. Methods:  We ascertained all first episodes of acute symptomatic seizure and unprovoked seizure due to central nervous system (CNS) infection, stroke, and traumatic brain injury (TBI). Subjects were residents of Rochester, Minnesota, identified through the Rochester Epidemiology Project’s records‐linkage system between 1/1/55 and 12/31/84. Information was collected on age, gender, seizure type, etiology, status epilepticus (SE), 30‐day and 10‐year mortality, and subsequent episodes of unprovoked seizure. Results:  Two hundred sixty‐two individuals experienced a first acute symptomatic seizure and 148 individuals experienced a first unprovoked seizure, all due to static brain lesions. Individuals with a first acute symptomatic seizure were 8.9 times more likely to die within 30 days compared to those with a first unprovoked seizure [95% confidence intervals (CI) = 3.5–22.5] after adjustment for age, gender, and SE. Among 30‐day survivors, the risk of 10‐year mortality did not differ. Over the 10‐year period, individuals with a first acute symptomatic seizure were 80% less likely to experience a subsequent unprovoked seizure compared with individuals with a first unprovoked seizure [adjusted rate ratio (RR) = 0.2, 95% CI = 0.2–0.4]. Discussion:  The prognosis of first acute symptomatic seizures differs from that of first unprovoked seizure when the etiology is stroke, TBI, and CNS infection. Acute symptomatic seizures have a higher early mortality and a lower risk for subsequent unprovoked seizure. These differences argue against the inclusion of acute symptomatic seizures as epilepsy.</description><identifier>ISSN: 0013-9580</identifier><identifier>EISSN: 1528-1167</identifier><identifier>DOI: 10.1111/j.1528-1167.2008.01945.x</identifier><identifier>PMID: 19374657</identifier><identifier>CODEN: EPILAK</identifier><language>eng</language><publisher>Oxford, UK: Blackwell Publishing Ltd</publisher><subject>Acute Disease ; Acute symptomatic seizure ; Adolescent ; Adult ; Age of Onset ; Aged ; Anticonvulsants. Antiepileptics. Antiparkinson agents ; Biological and medical sciences ; Central Nervous System Diseases - complications ; Chi-Square Distribution ; Child ; Child, Preschool ; Epidemiology ; Epilepsy ; Epilepsy - epidemiology ; Epilepsy - etiology ; Epilepsy - mortality ; Female ; Headache. Facial pains. Syncopes. Epilepsia. Intracranial hypertension. Brain oedema. Cerebral palsy ; Humans ; Infant ; Infant, Newborn ; Male ; Medical sciences ; Middle Aged ; Minnesota - epidemiology ; Mortality ; Nervous system (semeiology, syndromes) ; Neurology ; Neuropharmacology ; Pharmacology. Drug treatments ; Recurrence ; Risk Factors ; Seizure recurrence ; Seizures - classification ; Seizures - epidemiology ; Seizures - etiology ; Seizures - mortality ; Time Factors ; Young Adult</subject><ispartof>Epilepsia (Copenhagen), 2009-05, Vol.50 (5), p.1102-1108</ispartof><rights>Wiley Periodicals, Inc. © 2009 International League Against Epilepsy</rights><rights>2009 INIST-CNRS</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c4635-36b862f5e94b53f817380fba7027c2bf61d516e3a6a2a589d6aea3249f433743</citedby><cites>FETCH-LOGICAL-c4635-36b862f5e94b53f817380fba7027c2bf61d516e3a6a2a589d6aea3249f433743</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,780,784,27924,27925</link.rule.ids><backlink>$$Uhttp://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&amp;idt=21524679$$DView record in Pascal Francis$$Hfree_for_read</backlink><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/19374657$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Hesdorffer, Dale C.</creatorcontrib><creatorcontrib>Benn, Emma K. T.</creatorcontrib><creatorcontrib>Cascino, Gregory D.</creatorcontrib><creatorcontrib>Hauser, W. Allen</creatorcontrib><title>Is a first acute symptomatic seizure epilepsy? Mortality and risk for recurrent seizure</title><title>Epilepsia (Copenhagen)</title><addtitle>Epilepsia</addtitle><description>Summary Purpose:  To compare mortality and subsequent unprovoked seizure risk in a population‐based study of acute symptomatic seizure and first unprovoked seizure due to static brain lesions. Methods:  We ascertained all first episodes of acute symptomatic seizure and unprovoked seizure due to central nervous system (CNS) infection, stroke, and traumatic brain injury (TBI). Subjects were residents of Rochester, Minnesota, identified through the Rochester Epidemiology Project’s records‐linkage system between 1/1/55 and 12/31/84. Information was collected on age, gender, seizure type, etiology, status epilepticus (SE), 30‐day and 10‐year mortality, and subsequent episodes of unprovoked seizure. Results:  Two hundred sixty‐two individuals experienced a first acute symptomatic seizure and 148 individuals experienced a first unprovoked seizure, all due to static brain lesions. Individuals with a first acute symptomatic seizure were 8.9 times more likely to die within 30 days compared to those with a first unprovoked seizure [95% confidence intervals (CI) = 3.5–22.5] after adjustment for age, gender, and SE. Among 30‐day survivors, the risk of 10‐year mortality did not differ. Over the 10‐year period, individuals with a first acute symptomatic seizure were 80% less likely to experience a subsequent unprovoked seizure compared with individuals with a first unprovoked seizure [adjusted rate ratio (RR) = 0.2, 95% CI = 0.2–0.4]. Discussion:  The prognosis of first acute symptomatic seizures differs from that of first unprovoked seizure when the etiology is stroke, TBI, and CNS infection. Acute symptomatic seizures have a higher early mortality and a lower risk for subsequent unprovoked seizure. These differences argue against the inclusion of acute symptomatic seizures as epilepsy.</description><subject>Acute Disease</subject><subject>Acute symptomatic seizure</subject><subject>Adolescent</subject><subject>Adult</subject><subject>Age of Onset</subject><subject>Aged</subject><subject>Anticonvulsants. Antiepileptics. Antiparkinson agents</subject><subject>Biological and medical sciences</subject><subject>Central Nervous System Diseases - complications</subject><subject>Chi-Square Distribution</subject><subject>Child</subject><subject>Child, Preschool</subject><subject>Epidemiology</subject><subject>Epilepsy</subject><subject>Epilepsy - epidemiology</subject><subject>Epilepsy - etiology</subject><subject>Epilepsy - mortality</subject><subject>Female</subject><subject>Headache. Facial pains. Syncopes. Epilepsia. Intracranial hypertension. Brain oedema. Cerebral palsy</subject><subject>Humans</subject><subject>Infant</subject><subject>Infant, Newborn</subject><subject>Male</subject><subject>Medical sciences</subject><subject>Middle Aged</subject><subject>Minnesota - epidemiology</subject><subject>Mortality</subject><subject>Nervous system (semeiology, syndromes)</subject><subject>Neurology</subject><subject>Neuropharmacology</subject><subject>Pharmacology. Drug treatments</subject><subject>Recurrence</subject><subject>Risk Factors</subject><subject>Seizure recurrence</subject><subject>Seizures - classification</subject><subject>Seizures - epidemiology</subject><subject>Seizures - etiology</subject><subject>Seizures - mortality</subject><subject>Time Factors</subject><subject>Young Adult</subject><issn>0013-9580</issn><issn>1528-1167</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2009</creationdate><recordtype>article</recordtype><recordid>eNqNkE1r3DAQhkVoSLZp_kLQpb3Z1Ycl2YdSStg0CxuSQ6BHMdZKoK29diWbrvvrI2c322t0GcE870jzIIQpyWk6X7c5FazMKJUqZ4SUOaFVIfL9GVqcGh_QghDKs0qU5BJ9jHFLCFFS8Qt0SSuuCinUAv1aRQzY-RAHDGYcLI5T2w9dC4M3OFr_bwwW2943to_Td_zQhQEaP0wYdhscfPyNXRdwsGYMwe6Gt8gndO6gifb6WK_Q893y-fY-Wz_-XN3-WGemkFxkXNalZE7YqqgFdyVVvCSuBkWYMqx2km4ElZaDBAairDYSLHBWVK7gaQV-hb4cxvah-zPaOOjWR2ObBna2G6NO6zLOFEtgeQBN6GIM1uk--BbCpCnRs1O91bM6PavTs1P96lTvU_Tm-MZYt3bzP3iUmIDPRwCigcYF2BkfTxxLcwupqsR9O3B_k83p3R_Qy6fVfOMvzraScw</recordid><startdate>200905</startdate><enddate>200905</enddate><creator>Hesdorffer, Dale C.</creator><creator>Benn, Emma K. T.</creator><creator>Cascino, Gregory D.</creator><creator>Hauser, W. Allen</creator><general>Blackwell Publishing Ltd</general><general>Wiley-Blackwell</general><scope>IQODW</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope></search><sort><creationdate>200905</creationdate><title>Is a first acute symptomatic seizure epilepsy? Mortality and risk for recurrent seizure</title><author>Hesdorffer, Dale C. ; Benn, Emma K. T. ; Cascino, Gregory D. ; Hauser, W. Allen</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c4635-36b862f5e94b53f817380fba7027c2bf61d516e3a6a2a589d6aea3249f433743</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2009</creationdate><topic>Acute Disease</topic><topic>Acute symptomatic seizure</topic><topic>Adolescent</topic><topic>Adult</topic><topic>Age of Onset</topic><topic>Aged</topic><topic>Anticonvulsants. Antiepileptics. Antiparkinson agents</topic><topic>Biological and medical sciences</topic><topic>Central Nervous System Diseases - complications</topic><topic>Chi-Square Distribution</topic><topic>Child</topic><topic>Child, Preschool</topic><topic>Epidemiology</topic><topic>Epilepsy</topic><topic>Epilepsy - epidemiology</topic><topic>Epilepsy - etiology</topic><topic>Epilepsy - mortality</topic><topic>Female</topic><topic>Headache. Facial pains. Syncopes. Epilepsia. Intracranial hypertension. Brain oedema. Cerebral palsy</topic><topic>Humans</topic><topic>Infant</topic><topic>Infant, Newborn</topic><topic>Male</topic><topic>Medical sciences</topic><topic>Middle Aged</topic><topic>Minnesota - epidemiology</topic><topic>Mortality</topic><topic>Nervous system (semeiology, syndromes)</topic><topic>Neurology</topic><topic>Neuropharmacology</topic><topic>Pharmacology. Drug treatments</topic><topic>Recurrence</topic><topic>Risk Factors</topic><topic>Seizure recurrence</topic><topic>Seizures - classification</topic><topic>Seizures - epidemiology</topic><topic>Seizures - etiology</topic><topic>Seizures - mortality</topic><topic>Time Factors</topic><topic>Young Adult</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Hesdorffer, Dale C.</creatorcontrib><creatorcontrib>Benn, Emma K. T.</creatorcontrib><creatorcontrib>Cascino, Gregory D.</creatorcontrib><creatorcontrib>Hauser, W. Allen</creatorcontrib><collection>Pascal-Francis</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>Epilepsia (Copenhagen)</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Hesdorffer, Dale C.</au><au>Benn, Emma K. T.</au><au>Cascino, Gregory D.</au><au>Hauser, W. Allen</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Is a first acute symptomatic seizure epilepsy? Mortality and risk for recurrent seizure</atitle><jtitle>Epilepsia (Copenhagen)</jtitle><addtitle>Epilepsia</addtitle><date>2009-05</date><risdate>2009</risdate><volume>50</volume><issue>5</issue><spage>1102</spage><epage>1108</epage><pages>1102-1108</pages><issn>0013-9580</issn><eissn>1528-1167</eissn><coden>EPILAK</coden><abstract>Summary Purpose:  To compare mortality and subsequent unprovoked seizure risk in a population‐based study of acute symptomatic seizure and first unprovoked seizure due to static brain lesions. Methods:  We ascertained all first episodes of acute symptomatic seizure and unprovoked seizure due to central nervous system (CNS) infection, stroke, and traumatic brain injury (TBI). Subjects were residents of Rochester, Minnesota, identified through the Rochester Epidemiology Project’s records‐linkage system between 1/1/55 and 12/31/84. Information was collected on age, gender, seizure type, etiology, status epilepticus (SE), 30‐day and 10‐year mortality, and subsequent episodes of unprovoked seizure. Results:  Two hundred sixty‐two individuals experienced a first acute symptomatic seizure and 148 individuals experienced a first unprovoked seizure, all due to static brain lesions. Individuals with a first acute symptomatic seizure were 8.9 times more likely to die within 30 days compared to those with a first unprovoked seizure [95% confidence intervals (CI) = 3.5–22.5] after adjustment for age, gender, and SE. Among 30‐day survivors, the risk of 10‐year mortality did not differ. Over the 10‐year period, individuals with a first acute symptomatic seizure were 80% less likely to experience a subsequent unprovoked seizure compared with individuals with a first unprovoked seizure [adjusted rate ratio (RR) = 0.2, 95% CI = 0.2–0.4]. Discussion:  The prognosis of first acute symptomatic seizures differs from that of first unprovoked seizure when the etiology is stroke, TBI, and CNS infection. Acute symptomatic seizures have a higher early mortality and a lower risk for subsequent unprovoked seizure. These differences argue against the inclusion of acute symptomatic seizures as epilepsy.</abstract><cop>Oxford, UK</cop><pub>Blackwell Publishing Ltd</pub><pmid>19374657</pmid><doi>10.1111/j.1528-1167.2008.01945.x</doi><tpages>7</tpages></addata></record>
fulltext fulltext
identifier ISSN: 0013-9580
ispartof Epilepsia (Copenhagen), 2009-05, Vol.50 (5), p.1102-1108
issn 0013-9580
1528-1167
language eng
recordid cdi_proquest_miscellaneous_67323272
source Wiley
subjects Acute Disease
Acute symptomatic seizure
Adolescent
Adult
Age of Onset
Aged
Anticonvulsants. Antiepileptics. Antiparkinson agents
Biological and medical sciences
Central Nervous System Diseases - complications
Chi-Square Distribution
Child
Child, Preschool
Epidemiology
Epilepsy
Epilepsy - epidemiology
Epilepsy - etiology
Epilepsy - mortality
Female
Headache. Facial pains. Syncopes. Epilepsia. Intracranial hypertension. Brain oedema. Cerebral palsy
Humans
Infant
Infant, Newborn
Male
Medical sciences
Middle Aged
Minnesota - epidemiology
Mortality
Nervous system (semeiology, syndromes)
Neurology
Neuropharmacology
Pharmacology. Drug treatments
Recurrence
Risk Factors
Seizure recurrence
Seizures - classification
Seizures - epidemiology
Seizures - etiology
Seizures - mortality
Time Factors
Young Adult
title Is a first acute symptomatic seizure epilepsy? Mortality and risk for recurrent seizure
url http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-25T08%3A12%3A05IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Is%20a%20first%20acute%20symptomatic%20seizure%20epilepsy?%20Mortality%20and%20risk%20for%20recurrent%20seizure&rft.jtitle=Epilepsia%20(Copenhagen)&rft.au=Hesdorffer,%20Dale%20C.&rft.date=2009-05&rft.volume=50&rft.issue=5&rft.spage=1102&rft.epage=1108&rft.pages=1102-1108&rft.issn=0013-9580&rft.eissn=1528-1167&rft.coden=EPILAK&rft_id=info:doi/10.1111/j.1528-1167.2008.01945.x&rft_dat=%3Cproquest_cross%3E67323272%3C/proquest_cross%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c4635-36b862f5e94b53f817380fba7027c2bf61d516e3a6a2a589d6aea3249f433743%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=67323272&rft_id=info:pmid/19374657&rfr_iscdi=true